Medtech prototype builds play a defining role in early product development. In a new article for Medical Product Outsourcing, StarFish Medical Commercialization Manager Jason McGee explores how medtech prototype builds help startups show progress, reduce uncertainty, and move closer to commercial readiness. His feature highlights why thoughtful iteration supports stronger fundraising efforts and creates momentum for growing companies.

In the article, McGee explains how each prototype stage communicates tangible advancement. Instead of relying on vision alone, startups can demonstrate measurable progress that reinforces credibility with investors and partners. This visible movement through prototype milestones helps teams manage technical risk and frame their development strategy in a clear, disciplined way.

The discussion also touches on how prototypes influence valuation. Startups often face pressure to validate their direction quickly. By creating structured prototype iterations, teams can show steady refinement while addressing risks that might slow development. This helps support stronger valuations during fundraising and creates a more predictable path toward regulatory and commercial milestones.

McGee also notes a broader shift in the market. Acquirers and investors increasingly prioritize companies that can demonstrate commercial readiness. Prototype development has become a signal of this readiness, giving startups the ability to showcase both innovation and execution.

These themes offer helpful guidance for teams navigating early development. Readers will find insights on how structured iteration can support long term goals and strengthen confidence across stakeholders. To explore the full perspective, you can read McGee’s complete article on the MPO website.